Rowlinges Life Science
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Mepgud GV 1mg/500mg/0.2mg Tablet ER is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet ER
Mepgud GV 1mg/500mg/0.2mg Tablet ER is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Mepgud GV 1mg/500mg/0.2mg Tablet ER is to be taken empty stomach.
Mepgud GV 1mg/500mg/0.2mg Tablet ER is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Mepgud GV 1mg/500mg/0.2mg Tablet ER is a combination of three active ingredients: Glimepiride, Metformin and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It works by improving blood glucose control through multiple mechanisms including increasing insulin release from the pancreas, reducing liver glucose production, and inhibiting postprandial glucose absorption.
Like any medication, Mepgud GV 1mg/500mg/0.2mg Tablet ER can cause side effects. Common ones include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Mepgud GV 1mg/500mg/0.2mg Tablet ER is contraindicated in patients with known allergies to any of its components or excipients. It also shouldn't be used in patients with: moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, or existing metabolic acidosis including diabetic ketoacidosis.
No, combining alcohol with Mepgud GV 1mg/500mg/0.2mg Tablet ER is not recommended as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Mepgud GV 1mg/500mg/0.2mg Tablet ER can trigger hypoglycemia (low blood sugar). Symptoms may include: nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feelings of anxiety or shakiness. It's more likely to occur if you miss meals, drink alcohol, over-exercise or use other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential.
Store Mepgud GV 1mg/500mg/0.2mg Tablet ER in its original packaging, tightly sealed, in a cool, dry place. Refer to the label for specific storage instructions and do not dispose of unused medication without consulting your healthcare provider.